Study links spot urinary electrolytes to CHF hospitalization in dogs
Bottom line
A new multicenter retrospective study in the American Journal of Veterinary Research suggests that spot urinary electrolyte measurements taken after IV furosemide may help predict how quickly dogs with acute left-sided congestive heart failure from myxomatous mitral valve disease will decongest and how long they’ll stay hospitalized. According to the study abstract, the cases came from three referral hospitals and included dogs presenting between January 2024 and December 2025. The work adds to a growing body of veterinary cardiology research examining urine sodium and related indices as practical markers of diuretic responsiveness in dogs with CHF, an area that has drawn attention because decongestion is still often assessed with more subjective bedside measures. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the appeal is straightforward: a spot urine test could offer an earlier, more quantitative read on whether a dog is responding to loop diuretics, potentially helping teams identify poor natriuretic response sooner and adjust treatment plans more confidently. Prior canine work has linked urine sodium after IV furosemide with treatment efficacy and oxygen dependence in acute CHF, while other studies in stable MMVD have shown that urinary electrolyte interpretation is highly sensitive to sampling time after furosemide administration. Together, that means the new AJVR report is clinically interesting, but its usefulness in practice will depend on how reproducible the sampling protocol is and whether the findings hold up prospectively. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for the full paper’s detailed thresholds, timing recommendations, and whether prospective studies test spot urinary electrolytes as a real-time guide for inpatient diuretic escalation in dogs with acute CHF. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Study type
- Multicenter retrospective study
- Journal
- American Journal of Veterinary Research
- Population
- Dogs hospitalized for acute left-sided congestive heart failure secondary to myxomatous mitral valve disease
- Treatment
- Single IV bolus of furosemide before urinary electrolyte assessment
- Setting
- Three referral hospitals
- Study period
- January 2024 to December 2025
- Main finding
- Spot urinary electrolyte indices were associated with decongestion and duration of hospitalization
- Clinical use
- May help predict how quickly dogs decongest and how long they stay hospitalized
A newly published study in the American Journal of Veterinary Research points to spot urinary electrolytes as a potentially useful bedside marker in dogs hospitalized for acute left-sided congestive heart failure secondary to myxomatous mitral valve disease. Based on the abstract, the multicenter retrospective analysis evaluated dogs treated with IV furosemide at three referral hospitals and found an association between urinary electrolyte indices, decongestion, and duration of hospitalization. That’s notable because clinicians managing acute CHF still need better objective tools to gauge early diuretic response in real time. (pubmed.ncbi.nlm.nih.gov)
The idea didn’t emerge in a vacuum. In human heart failure care, spot urine sodium has become an increasingly studied marker of diuretic responsiveness, with lower values associated with poorer decongestion and longer hospital stays. Veterinary cardiology has been moving in the same direction. A 2024 Journal of Veterinary Internal Medicine study reported that urine sodium concentration after IV furosemide in dogs with acute CHF correlated with treatment duration and treatment efficacy, including successful discontinuation of supplemental oxygen during hospitalization. (pmc.ncbi.nlm.nih.gov)
There’s also important methodological context behind the new report. Earlier work in dogs with stable ACVIM stage C MMVD found that urinary sodium, chloride, and sodium-to-potassium ratio are significantly higher within six hours of oral furosemide administration, underscoring that timing of sample collection materially affects interpretation. In other words, urinary electrolytes may be clinically useful, but only if clinicians are disciplined about when samples are obtained relative to diuretic dosing. (sciencedirect.com)
From the abstract information available, the AJVR study focused specifically on acute left-sided CHF caused by MMVD, the most common acquired cardiac disease in dogs and a leading cause of CHF in small-breed patients. The study population came from cases seen between January 2024 and December 2025, and all dogs received a single IV bolus of furosemide before urinary electrolyte assessment. While the full article details weren’t fully accessible in search results, the framing suggests the authors were evaluating whether spot urinary indices could serve as a proxy for natriuretic response and, by extension, inpatient decongestion success. That aligns closely with the direction of recent canine CHF research. (sciencedirect.com)
Direct expert reaction to this specific AJVR paper was limited in publicly available sources, but the broader field has already signaled interest. A 2023 review on quantifying loop diuretic responsiveness in dogs with CHF described urine sodium concentration and urine volume as promising objective tools, borrowing from standards increasingly used in human medicine. More recently, a 2026 JVIM report on dogs receiving oral loop diuretics for chronic CHF showed the concept remains under active investigation, even though correlations were not significant in that small chronic-care cohort. That mixed picture suggests enthusiasm, but also a need for careful validation across settings. (onlinelibrary.wiley.com)
Why it matters: For veterinary professionals, the practical value is the possibility of moving beyond subjective endpoints alone, such as respiratory effort, radiographic improvement, or time on oxygen, when assessing whether a hospitalized dog is responding adequately to furosemide. If spot urinary electrolytes can reliably identify weak natriuretic response early, they could help clinicians escalate diuretic therapy sooner, consider adjunctive strategies, and potentially shorten hospitalization for some patients. At the same time, the literature also points to confounders, including sampling time and the cardiorenal risks that accompany aggressive diuresis in dogs with CHF. (pmc.ncbi.nlm.nih.gov)
The bigger takeaway is that this is another step toward more quantitative inpatient heart failure management in dogs, especially in MMVD cases where recurrent congestion, renal tradeoffs, and hospitalization burden are everyday realities. The study doesn’t by itself establish a new standard of care, but it strengthens the case for urine-based monitoring as a low-tech, clinically relevant tool that could fit referral and specialty workflows if standardized thresholds and timing are defined. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next key questions are whether the authors report actionable cutoff values, whether those values predict outcomes prospectively, and whether urine-guided diuretic protocols can improve decongestion without increasing kidney injury or electrolyte complications in dogs with acute CHF. (pmc.ncbi.nlm.nih.gov)